Hypermutation as an Evolutionary Mechanism for <i>Achromobacter xylosoxidans</i> in Cystic Fibrosis Lung Infection

• Main Authors: Laura Veschetti, Angela Sandri, Helle Krogh Johansen, Maria M. Lleò, Giovanni Malerba
• Format: Article
• Language: English
• Published: MDPI AG 2020-01-01
• Series: Pathogens
• Subjects: lung infection; opportunistic pathogen; bacterial evolution; comparative genomics; clonal diversification
• Online Access: https://www.mdpi.com/2076-0817/9/2/72

<i>Achromobacter xylosoxidans</i> can cause chronic infections in the lungs of patients with cystic fibrosis (CF) by adapting to the specific environment. The study of longitudinal isolates allows to investigate its within-host evolution to unravel the adaptive mechanisms contributing to successful colonization. In this study, four clinical isolates longitudinally collected from two chronically infected patients underwent whole genome sequencing, de novo assembly and sequence analysis. Phenotypic assays were also performed. The isolates coming from one of the patients (patient A) presented a greater number of genetic variants, diverse integrative and conjugative elements, and different protease secretion. In the first of these isolates (strain A1), we also found a large deletion in the <i>mutS</i> gene, involved in DNA mismatch repair (MMR). In contrast, isolates from patient B showed a lower number of variants, only one integrative and mobilizable element, no phenotypic changes, and no mutations in the MMR system. These results suggest that in the two patients the establishment of a chronic infection was mediated by different adaptive mechanisms. While the strains isolated from patient B showed a longitudinal microevolution, strain A1 can be clearly classified as a hypermutator, confirming the occurrence and importance of this adaptive mechanism in <i>A. xylosoxidans</i> infection.